A new antibody shot that protects babies against RSV infection could be struggling to gain traction, Philadelphia researchers ...

Each year in the UK, 30,000 children under the age of five are hospitalised with RSV and it causes around 30 infant deaths.

GSK's vaccine for RSV was submitted to Health Canada for review in November 2022. It did not receive priority review, which means the agency has 12 months to decide whether to approve it.

Respiratory syncytial virus, or RSV, burst into public consciousness last fall as one of the three viruses behind a “tripledemic” that overwhelmed hospitals, particularly in the pediatric sector.

An RSV vaccine has been available to pregnant women in Northern Ireland since last September and is offered from 28 weeks of ...

Moderna is developing a three-in-one vaccine against COVID-19, flu and RSV. The vaccine manufacturer is actively promoting the shot and hoping for regulatory approval in the next year.

Today, the Federation of Medical Women of Canada (FMWC) released its latest white paper through the Maternal RSV Task Force—a ...

Multiple RSV vaccines for adults are rolling out in the months ahead, along with two monoclonal antibody shots to provide protection for infants. Yet accessing the various shots will depend on ...

Parental trust in clinicians drove RSV vaccine uptake, while confusion and limited access to reliable information hindered ...

The agency's most recent Respiratory Virus Report stated that RSV activity "is above expected levels for this time of year." The cases are only predicted to grow as the country enters its first cold ...

RSV can be a dangerous and potentially deadly disease, especially for infants; about 58,000 to 80,000 children under five are hospitalized each year and up to 300 die from RSV in the U.S ...

A disastrous first attempt at testing an RSV vaccine in infants in the 1960s “set back RSV vaccine development in infants for decades,” Papenburg explained. That vaccine candidate not only failed to ...